Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe
This study provides evidence on the development and implementation of a new PC algorithm for MASLD screening and management. Variations among participating settings in algorithm implementation are indicative of context-specific particularities. Further research is necessary for integrating such pathways in tailored interventions to tackle this emerging public health issue.
Authors
- Ger H. Koek (ORCID: https://orcid.org/0000-0002-7863-392X)
- Irini Gergianaki
- Christos Lionis (ORCID: https://orcid.org/0000-0002-9324-2839)
- Leen Heyens (ORCID: https://orcid.org/0000-0003-4850-6011)
- Marilena Anastasaki (ORCID: https://orcid.org/0000-0003-2306-1626)
- Juan Manuel Mendive (ORCID: https://orcid.org/0000-0001-8095-7707)
- Rosario Hernández-Ibáñez
- Jean Muris (ORCID: https://orcid.org/0000-0002-8780-476X)
- Sophia Papadakis (ORCID: https://orcid.org/0009-0005-2414-7036)
- Montserrat Garcı́a-Retortillo (ORCID: https://orcid.org/0000-0001-6783-7604)
- Alba Martínez-Escudé (ORCID: https://orcid.org/0000-0003-0667-1609)
- Sivaropoulos Nektarios
- Eftychios Aligizakis
- Loucas Papastamatiou
- Foteini Anastasiou
- Carlos de Juan-Asenjo
- Nikoleta Grillaki
- Eleni Boutzoukaki
Institutions
- Mediterranean Agronomic Institute of Chania (GR)
- University of Crete (GR)
- Maastricht University (NL)
- FORTH Institute of Mediterranean Studies (GR)
- Catalan Society of Family and Community Medicine (ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- Hospital Del Mar (ES)
- Ziekenhuis Oost-Limburg (BE)
- Marine Technology Unit (ES)
- European Centre for Disease Prevention and Control (SE)
- Hasselt University (BE)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3389/fmed.2024.1383112
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Gilead Sciences